Clinical Trial Update: Exploratory Study to Evaluate Various Pharmacodynamic Effects of Subcutaneously Infused or Injected Pramlintide in Obese Subjects [Phase 2]

View source ↗

Summary

A Phase 2 exploratory trial evaluated the pharmacodynamic effects of subcutaneously administered pramlintide in overweight/obese subjects; the study has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Symlin (pramlintide)

Snippet

Sponsor: AstraZeneca | Conditions: Overweight, Obesity | Phase 2 | Status: COMPLETED